查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402032

到 2030 年局部麻醉市场预测：按类型、给药途径、最终用户和地区进行的全球分析

Local Anesthesia Market Forecasts to 2030 - Global Analysis By Type, Route of Administration, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球局部麻醉市场规模为 30 亿美元，预计在预测期内将以 8.4% 的复合年增长率成长，到 2030 年达到 53 亿美元。

局部麻醉是一种用于暂时麻木身体某些部位以缓解不适的医疗程序。将利多卡因或奴佛卡因等麻醉剂直接注射到患处，以阻断神经讯号并停止疼痛感。在接受牙科治疗、皮肤手术、关节注射等治疗时，患者可以保持清醒和意识，不像全身麻醉会让患者失去意识。

根据美国整形外科医师协会统计，2020年美国进行了230万例整容手术、1,320万例美容微创手术和680万例重组手术，比2019年增加了3%。

外科手术不断增加

局部麻醉剂越来越多地用于各种外科手术，因为它们可以缓解某些不适而不使患者失去知觉。由于整形外科、牙科和皮肤科等许多医学专业对外科手术的需求不断增加，有效的疼痛管理是必要的。此外，门诊治疗和外科手术的日益普及也推动了对局部麻醉剂的需求。

缺乏熟练劳动力

局部麻醉在各种医疗手术中发挥重要作用，局部麻醉剂的给药需要专业知识和训练。然而，缺乏熟练的专业人员，例如麻醉师和护士，他们拥有安全有效实施局部麻醉所需的专业知识。这种短缺限制了局部麻醉服务的可用性，导致手术延误和患者疼痛控制不足，并且是市场扩张的主要障碍。

技术开发

自动化药物输送和监测系统的开发可以帮助准确管理药物给药、提高病人安全并减轻医疗保健提供者的负担。药物基因组学、奈米技术和自动麻醉技术等技术发展越来越多地应用于各种外科手术。此外，该产业采用创新解决方案不仅会提高局部麻醉剂的有效性，还会推动市场扩张。

与副作用和过敏反应相关的风险

局部麻醉剂会引起过敏，并对敏感族群产生副作用。这包括呼吸困难、脸部和喉咙肿胀以及低血压等症状。在极少数情况下，局部麻醉可能会导致暂时性或永久性神经损伤，从而导致麻木或瘫痪。此外，这些副作用和过敏反应会增加患者和医疗保健提供者的焦虑，并影响局部麻醉剂的需求和使用。

COVID-19 的影响

COVID-19大流行导致手术延迟、选择性治疗中断以及医疗保健优先事项发生变化，对局部麻醉市场产生了负面影响。由于封锁和安全问题导致非紧急医疗干预措施急剧下降，影响了局部麻醉剂的需求。其他导致市场下滑的因素包括患者偏好的变化、医疗资源有限和经济状况不确定。

预计製药领域在预测期内将是最大的

由于缓释性製剂（包括外用製剂、注射剂和经皮吸收贴片）的开发，预计製药领域将占据最大占有率。持续研究和配方创新的目标是延长麻醉时间、减少副作用并改善患者的整体体验。因此，全世界进行的医疗和牙科手术数量不断增加，增加了对各种有效局部麻醉剂製剂的需求。

预计硬脊膜外麻醉领域在预测期内复合年增长率最高

预计硬膜外麻醉领域在预测期内将出现良好的成长。硬膜外麻醉常用于缓解分娩、手术和其他医疗过程中的不适。导管设计、影像技术和药物配方的不断发展正在促进硬膜外麻醉的改进。持续开发的目标是使硬膜外麻醉技术更安全、更准确。因此，这些因素正在显着推动市场扩张。

占有率最大的地区

由于中国、印度和日本等国家在麻醉剂输送系统、配方和给药方法方面取得了前沿进步，亚太地区在预测期内获得了最大的市场占有率。电脑辅助麻醉剂给药和超音波引导手术就是例子，它们提供了准确性、安全性和病人舒适度。因此，越来越多的医疗设施和高素质医疗保健专业人员，加上该地区致力于实施尖端医疗技术，正在推动市场扩张。

复合年增长率最高的地区：

由于先进的医疗基础设施和完善的医疗保健系统，预计北美在预测期内将出现盈利成长。先进的麻醉输送系统和监测设备等技术进步体现了该地区对尖端医疗保健的承诺。此外，该地区的监管环境受到美国FDA 和加拿大卫生署等机构制定的严格标准的监管，确保了高品质和安全的实践，从而推动了市场扩张。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球局部麻醉市场：依类型

  • 公式
    • 注射液
    • 局部乳霜和软膏
    • 喷
    • 修补
    • 滴剂和凝胶
  • 运输方式
    • 吸入
    • 注射
    • 静脉 (IV)局部麻醉
    • 口服含片和漱口水
  • 其他类型

第六章全球局部麻醉市场：依给药途径

  • 浸润
  • 硬脊膜外麻醉
  • 膀胱内（膀胱）途径
  • 鼻内途径
  • 关节内 (IA) 路线
  • 骨内途径
  • 经皮途径
    • 共晶片
    • 离子电渗透疗法
    • 磁泳
  • 邻里
  • 其他给药途径

第七章全球局部麻醉市场：依最终使用者分类

  • 牙医诊所
  • 门诊手术中心
  • 医院和诊所
  • 其他最终用户

第八章全球局部麻醉市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • 3M
  • Pfizer Inc.
  • Mylan
  • Molteno
  • B. Braun Melsungen AG
  • Septodont
  • AstraZeneca
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals
  • Dentsply Sirona
  • Teva Pharmaceutical Industries
  • Piramal Enterprises
Product Code: SMRC24552

According to Stratistics MRC, the Global Local Anesthesia Market is accounted for $3.0 billion in 2023 and is expected to reach $5.3 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Local anesthesia is a medical treatment used to temporarily numb a specific area of the body to eliminate discomfort. It entails injecting anesthetics, such as lidocaine or novocaine, directly into the affected area to block nerve signals and stop pain perception. When receiving dental work, skin surgery, or joint injections, patients can stay awake and conscious, unlike with general anesthesia, which causes unconsciousness.

According to the American Society of Plastic Surgeons, in 2020, 2.3 million cosmetic surgical procedures, 13.2 million cosmetic minimally invasive procedures, and 6.8 million reconstructive procedures were performed in the United States 2020, representing a 3% increase over 2019.

Market Dynamics:

Driver:

Rising surgical procedures

Local anesthetics are becoming more and more used in a variety of surgical procedures because they can relieve specific discomfort without knocking patients out. Effective pain management is necessary due to the growing need for surgical procedures in a number of medical specialties, such as orthopaedics, dentistry, and dermatology. Additionally, the increasing prevalence of outpatient treatments and surgical improvements is driving up demand for local anesthetics.

Restraint:

Lack of skilled workforce

Local anesthesia plays a vital role in various medical procedures, administering local anesthetics requires specialized knowledge and training. However, there is a shortage of skilled professionals, such as anaesthesiologists or nurse anesthetists, who possess the necessary expertise in administering local anesthesia safely and effectively. This scarcity limits the availability of local anesthesia services, leading to delays in procedures or inadequate pain management for patients which significantly hamper market expansion.

Opportunity:

Technological developments

The development of automated systems for anesthesia delivery and monitoring helps in maintaining precise control over drug administration, improving patient safety, and reducing the workload on healthcare providers. Technological developments like pharmacogenomics, nanotechnology and automated anesthesia techniques are increasingly being employed for various surgical procedures. Furthermore, as the industry adopts innovative solutions, not only enhances the efficacy of local anesthetics but also propels market expansion.

Threat:

Risks associated with side effects and allergic reactions

The local anesthetics may develop allergy, which could result adverse reactions in sensitive individuals. This can include symptoms such as difficulty breathing, swelling of the face or throat, and a drop in blood pressure. In rare cases, local anesthesia may cause temporary or, very rarely, permanent nerve damage causing tingling and numbness. Furthermore, these side effects and allergic reactions can raise the anxiety of patients and healthcare providers, which may impact the demand for and uptake of local anesthetics.

COVID-19 Impact

The COVID-19 pandemic had a detrimental effect on the local anesthesia market as it caused delays in surgeries, disruptions in elective treatments, and a change in healthcare priorities. The need for local anesthetics was impacted by a sharp decline in non-urgent medical interventions brought on by lockdowns and safety concerns. Additional factors contributing to a slowdown included changing patient preferences, limited healthcare resources, and uncertain economic conditions which gradually hamper the market size.

The formulations segment is expected to be the largest during the forecast period

The formulations segment is estimated to hold the largest share, due to the development of prolonged-release or extended-release formulations including topical, injectables, and transdermal patches. The goal of ongoing research and formulation innovation is to prolong anesthesia, lessen side effects, and enhance the overall patient experience. Therefore, the growing number of medical and dental operations performed worldwide is driving the need for a variety of efficient local anesthetic formulations.

The epidural segment is expected to have the highest CAGR during the forecast period

The epidural segment is anticipated to have lucrative growth during the forecast period. This approach is frequently employed to relieve discomfort during labor, surgery, and other medical operations. Continuous developments in catheter design, imaging techniques, and drug formulations contribute to the refinement of epidural anesthesia. The goal of ongoing developments is to make epidural anesthetic techniques safer and more accurate. Thus, these factors significantly drive market expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to cutting-edge advancements in anesthetic delivery systems, formulations, and administration methods in nations like China, India, and Japan. Computer-assisted anesthetic delivery and ultrasound-guided surgeries are some of the examples included, which provide accuracy, safety, and patient comfort. Therefore, an increasing number of medical facilities and highly qualified healthcare workers, coupled with the region's dedication to implementing cutting-edge medical technologies which propels market expansion.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to advanced healthcare infrastructure and a well-established medical system. Technological advancements, including sophisticated anesthesia delivery systems and monitoring devices, characterize the region's commitment to cutting-edge healthcare practices. Additionally, the region's regulatory landscape, governed by stringent standards set by entities like the U.S. FDA and Health Canada, ensures high-quality and safe practices which are boosting market expansion.

Key players in the market:

Some of the key players in the Local Anesthesia Market include 3M, Pfizer Inc., Mylan, Molteno, B. Braun Melsungen AG, Septodont, AstraZeneca, Fresenius SE & Co. KGaA , Hikma Pharmaceuticals, Dentsply Sirona, Teva Pharmaceutical Industries and Piramal Enterprises.

Key Developments:

In August 2023, 3M announced it has completed the sale of certain assets from its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A.

In July 2023, Flagship Pioneering, Inc. and Pfizer Inc. announced the companies have partnered to create a new pipeline of innovative medicines.

In July 2023, 3M Health Information Systems (HIS) announced that U.S. News & World Report will incorporate the 3M™ Ambulatory Potentially Preventable Complications software.

Types Covered:

  • Formulations
  • Delivery Methods
  • Other Types

Route of Administrations Covered:

  • Infiltration
  • Epidural
  • Intravesical (Bladder) Route
  • Intranasal Route
  • Intra-Articular (IA) Route
  • Intra-Osseous Route
  • Transdermal Route
  • Peripheral
  • Other Route of Administrations

End Users Covered:

  • Dental Clinics
  • Ambulatory Surgical Centers
  • Hospitals and Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Local Anesthesia Market, By Type

  • 5.1 Introduction
  • 5.2 Formulations
    • 5.2.1 Injectable Solutions
    • 5.2.2 Topical Creams and Ointments
    • 5.2.3 Sprays
    • 5.2.4 Patches
    • 5.2.5 Drops and Gels
  • 5.3 Delivery Methods
    • 5.3.1 Inhalation
    • 5.3.2 Injections
    • 5.3.3 Intravenous (IV) Regional Anesthesia
    • 5.3.4 Oral Lozenges and Gargles
  • 5.4 Other Types

6 Global Local Anesthesia Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Infiltration
  • 6.3 Epidural
  • 6.4 Intravesical (Bladder) Route
  • 6.5 Intranasal Route
  • 6.6 Intra-Articular (IA) Route
  • 6.7 Intra-Osseous Route
  • 6.8 Transdermal Route
    • 6.8.1 Eutectic Patches
    • 6.8.2 Iontophoresis
    • 6.8.3 Magnetophoresis
  • 6.9 Peripheral
  • 6.10 Other Route of Administrations

7 Global Local Anesthesia Market, By End User

  • 7.1 Introduction
  • 7.2 Dental Clinics
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Hospitals and Clinics
  • 7.4 Other End Users

8 Global Local Anesthesia Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M
  • 10.2 Pfizer Inc.
  • 10.3 Mylan
  • 10.4 Molteno
  • 10.5 B. Braun Melsungen AG
  • 10.6 Septodont
  • 10.7 AstraZeneca
  • 10.8 Fresenius SE & Co. KGaA
  • 10.9 Hikma Pharmaceuticals
  • 10.10 Dentsply Sirona
  • 10.11 Teva Pharmaceutical Industries
  • 10.12 Piramal Enterprises

List of Tables

  • Table 1 Global Local Anesthesia Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Local Anesthesia Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Local Anesthesia Market Outlook, By Formulations (2021-2030) ($MN)
  • Table 4 Global Local Anesthesia Market Outlook, By Injectable Solutions (2021-2030) ($MN)
  • Table 5 Global Local Anesthesia Market Outlook, By Topical Creams and Ointments (2021-2030) ($MN)
  • Table 6 Global Local Anesthesia Market Outlook, By Sprays (2021-2030) ($MN)
  • Table 7 Global Local Anesthesia Market Outlook, By Patches (2021-2030) ($MN)
  • Table 8 Global Local Anesthesia Market Outlook, By Drops and Gels (2021-2030) ($MN)
  • Table 9 Global Local Anesthesia Market Outlook, By Delivery Methods (2021-2030) ($MN)
  • Table 10 Global Local Anesthesia Market Outlook, By Inhalation (2021-2030) ($MN)
  • Table 11 Global Local Anesthesia Market Outlook, By Injections (2021-2030) ($MN)
  • Table 12 Global Local Anesthesia Market Outlook, By Intravenous (IV) Regional Anesthesia (2021-2030) ($MN)
  • Table 13 Global Local Anesthesia Market Outlook, By Oral Lozenges and Gargles (2021-2030) ($MN)
  • Table 14 Global Local Anesthesia Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 15 Global Local Anesthesia Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 16 Global Local Anesthesia Market Outlook, By Infiltration (2021-2030) ($MN)
  • Table 17 Global Local Anesthesia Market Outlook, By Epidural (2021-2030) ($MN)
  • Table 18 Global Local Anesthesia Market Outlook, By Intravesical (Bladder) Route (2021-2030) ($MN)
  • Table 19 Global Local Anesthesia Market Outlook, By Intranasal Route (2021-2030) ($MN)
  • Table 20 Global Local Anesthesia Market Outlook, By Intra-Articular (IA) Route (2021-2030) ($MN)
  • Table 21 Global Local Anesthesia Market Outlook, By Intra-Osseous Route (2021-2030) ($MN)
  • Table 22 Global Local Anesthesia Market Outlook, By Transdermal Route (2021-2030) ($MN)
  • Table 23 Global Local Anesthesia Market Outlook, By Eutectic Patches (2021-2030) ($MN)
  • Table 24 Global Local Anesthesia Market Outlook, By Iontophoresis (2021-2030) ($MN)
  • Table 25 Global Local Anesthesia Market Outlook, By Magnetophoresis (2021-2030) ($MN)
  • Table 26 Global Local Anesthesia Market Outlook, By Peripheral (2021-2030) ($MN)
  • Table 27 Global Local Anesthesia Market Outlook, By Other Route of Administrations (2021-2030) ($MN)
  • Table 28 Global Local Anesthesia Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Local Anesthesia Market Outlook, By Dental Clinics (2021-2030) ($MN)
  • Table 30 Global Local Anesthesia Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 31 Global Local Anesthesia Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
  • Table 32 Global Local Anesthesia Market Outlook, By Other End Users (2021-2030) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.